once monthly glp 1 agonist PDB-101: Molecule of the Month: GLP-1 Receptor Agonists ADA 2026 confirmed what many
Description
Pausing GLP-1 Therapy Led to Consequences BMJ Medicine , followed more than 333,000 American veterans with type 2 diabetes for three years
A study published in Frontiers in Endocrinology reported that these medications may increase the risk of pregnancy complications and birth defects
GLP-1 RAs demonstrated a beneficial effect on weight loss as opposed to the weight gain seen with insulin
Socioeconomic aspects of incretin-based therapy
As a general principle, most DPP-4 inhibitors require dose reduction or avoidance in moderate-to-severe renal impairment
